Prabhudas Lilladher buys Ipca target Rs 2200

GreyOak summary

Prabhudas Lilladher maintains a Buy rating on Ipca Laboratories with a revised target price of Rs 2,200. The broker cites strong EBITDA growth of 21% YoY and projected revenue growth of 15% for FY27 as key drivers. The stock is valued at 30x P/E on FY28E earnings.